EU Plans To Pressure Japan To Drop Nontariff Barriers On Drug Imports
This article was originally published in PharmAsia News
Japan is expected to come under pressure from the European Union to drop its nontariff barriers to imports of pharmaceuticals as part of a free-trade agreement set to enter formal negotiations by the end of the month.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.